Oncology
Focusing on solid tumor niches with significant unmet needs to deliver differentiated, innovative solutions.
The product information on this website is intended for healthcare professionals only.
The products shown here may not be available in all countries or regions.
-
Megaxia®megestrol acetate oral suspension*The marketing authorization holder (MAH) is TWi Pharmaceuticals, Inc. (TWi), while GenSci is authorized for commercializing the product in mainland China, Hong Kong, Macau, and Singapore.
-
Episil®oral liquid*The marketing authorization holder (MAH) is Solasia Pharma K.K. , while GenSci is authorized for commercializing the product in China.
The product information on this website is intended for healthcare professionals only.
The products shown here may not be available in all countries or regions.